Overview

To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatmen

Status:
Unknown status

Trial end date:
2017-04-01

Target enrollment:

Participant gender:

Summary

To evaluate the effect of concomitant administration of Probucol and Cilostazol (based on Atorvastatin treatment) on the atherosclerosis related markers (including the thickness of the Achilles tendon) in severe hypercholesterolemia subject, through the observation of the thickness of the Achilles tendon, the thickness of mean carotid intima-media, anti-oxidation biomarkers and serum lipid profile.

Phase:

Phase 4

Details

Lead Sponsor:

Otsuka Beijing Research Institute

Treatments:

Atorvastatin
Atorvastatin Calcium
Cilostazol
Probucol